319 related articles for article (PubMed ID: 10353397)
21. Photo catalogue for the classification of cell colonies in the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0.
Maire MA; Rast C; Vasseur P
Mutat Res; 2012 Apr; 744(1):97-110. PubMed ID: 22207274
[TBL] [Abstract][Full Text] [Related]
22. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay.
Maire MA; Pant K; Phrakonkham P; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Bohnenberger S; Kunkelmann T; Schulz M; Vasseur P
Mutat Res; 2012 Apr; 744(1):76-81. PubMed ID: 22198328
[TBL] [Abstract][Full Text] [Related]
23. Use of the Syrian hamster embryo (SHE) cell transformation assay for predicting the carcinogenic potential of chemicals. Introduction.
Yamasaki H
Mutat Res; 1996 Sep; 356(1):1-3. PubMed ID: 8841472
[No Abstract] [Full Text] [Related]
24. Development of human cell models for assessing the carcinogenic potential of chemicals.
Pang Y; Li W; Ma R; Ji W; Wang Q; Li D; Xiao Y; Wei Q; Lai Y; Yang P; Chen L; Tang S; Lin Y; Zhuang Z; Zheng Y; Chen W
Toxicol Appl Pharmacol; 2008 Nov; 232(3):478-86. PubMed ID: 18778725
[TBL] [Abstract][Full Text] [Related]
25. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0 for assessment of carcinogenic potential of chemicals.
Maire MA; Pant K; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Kunz-Bohnenberger S; Kunkelmann T; Engelhardt G; Schulz M; Vasseur P
Mutat Res; 2012 Apr; 744(1):64-75. PubMed ID: 22227405
[TBL] [Abstract][Full Text] [Related]
26. Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells.
Maeshima H; Ohno K; Tanaka-Azuma Y; Nakano S; Yamada T
Toxicol In Vitro; 2009 Feb; 23(1):148-57. PubMed ID: 19000923
[TBL] [Abstract][Full Text] [Related]
27. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds.
Kerckaert GA; LeBoeuf RA; Isfort RJ
Toxicol Sci; 1998 Feb; 41(2):189-97. PubMed ID: 9520355
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of potential carcinogenic properties of Tołpa Peat Preparation in vitro.
Koziorowska J; Anuszewska E
Acta Pol Pharm; 1994; 51(1):101-2. PubMed ID: 7976430
[TBL] [Abstract][Full Text] [Related]
29. The testing of chemicals in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential.
Engelhardt G; Schwind KR; Mussler B
Toxicol In Vitro; 2004 Apr; 18(2):213-8. PubMed ID: 14757112
[TBL] [Abstract][Full Text] [Related]
30. A Bhas 42 cell transformation assay on 98 chemicals: the characteristics and performance for the prediction of chemical carcinogenicity.
Sakai A; Sasaki K; Muramatsu D; Arai S; Endou N; Kuroda S; Hayashi K; Lim YM; Yamazaki S; Umeda M; Tanaka N
Mutat Res; 2010 Sep; 702(1):100-22. PubMed ID: 20656056
[TBL] [Abstract][Full Text] [Related]
31. Morphological transformation of Syrian hamster embryo cells by mezerein.
Tu AS; Tennant RW; Spalding JW
Cancer Lett; 1992 Feb; 62(2):159-65. PubMed ID: 1540943
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the morphological transformation of Syrian hamster embryo (SHE) cells by reducing incubation time of the target cells.
Zhang H; Borman HD; Myhr BC
Mutat Res; 2004 Apr; 548(1-2):1-7. PubMed ID: 15063130
[TBL] [Abstract][Full Text] [Related]
33. Two new approaches to improve the analysis of BALB/c 3T3 cell transformation assay data.
Hoffmann S; Hothorn LA; Edler L; Kleensang A; Suzuki M; Phrakonkham P; Gerhard D
Mutat Res; 2012 Apr; 744(1):36-41. PubMed ID: 22178130
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals.
Isfort RJ; Kerckaert GA; LeBoeuf RA
Mutat Res; 1996 Sep; 356(1):11-63. PubMed ID: 8841474
[TBL] [Abstract][Full Text] [Related]
35. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis.
Benigni R; Bossa C; Tcheremenskaia O
Mutagenesis; 2013 Jan; 28(1):107-16. PubMed ID: 23132285
[TBL] [Abstract][Full Text] [Related]
36. ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study.
Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L; Vanparys P
Mutat Res; 2012 Apr; 744(1):12-9. PubMed ID: 22138617
[TBL] [Abstract][Full Text] [Related]
37. Studies of tumor promoters with the Syrian hamster embryo cell transformation assay.
Sanner T; Rivedal E
Carcinog Compr Surv; 1985; 9():167-78. PubMed ID: 4053072
[No Abstract] [Full Text] [Related]
38. Classification of agents using Syrian hamster embryo (SHE) cell transformation assay (CTA) with ATR-FTIR spectroscopy and multivariate analysis.
Ahmadzai AA; Trevisan J; Pang W; Riding MJ; Strong RJ; Llabjani V; Pant K; Carmichael PL; Scott AD; Martin FL
Mutagenesis; 2015 Sep; 30(5):603-12. PubMed ID: 25925069
[TBL] [Abstract][Full Text] [Related]
39. Prevalidation study of the BALB/c 3T3 cell transformation assay for assessment of carcinogenic potential of chemicals.
Tanaka N; Bohnenberger S; Kunkelmann T; Munaro B; Ponti J; Poth A; Sabbioni E; Sakai A; Salovaara S; Sasaki K; Thomas BC; Umeda M
Mutat Res; 2012 Apr; 744(1):20-9. PubMed ID: 22198331
[TBL] [Abstract][Full Text] [Related]
40. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 6.7 for assessment of carcinogenic potential of chemicals.
Pant K; Bruce SW; Sly JE; Kunkelmann T; Kunz-Bohnenberger S; Poth A; Engelhardt G; Schulz M; Schwind KR
Mutat Res; 2012 Apr; 744(1):54-63. PubMed ID: 22178964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
